22 Scopus citations


The paradigm of metastasis has been significantly remodeled by the incorporation of cancer dormancy as a mechanism to explain long-term remission intervals followed by relapse. There is overall consensus on the potential impact of better understanding dormancy. Key cancer-cell autonomous and microenvironmental mechanisms might explain this biology and, in turn, the timing of metastasis. However, the approach and feasibility to apply this biology to clinical trials has been controversial. The discussion here provides insight into how these controversies are being resolved by the development of active clinical trials, thus bringing to reality opportunities to target cancer dormancy.

Original languageEnglish
Pages (from-to)4673-4675
Number of pages3
JournalCancer Research
Issue number18
StatePublished - 15 Sep 2021


Dive into the research topics of 'Translating the science of cancer dormancy to the clinic'. Together they form a unique fingerprint.

Cite this